Polish pharma company posts record profits and achieves its strategic goals

This result translates into growth of 4% as compared to the previous year. The implemented cost cutting program has also led to an improvement of the company's net profitability, which rose from 1.16% in 2004 to 1.37% last year. Based on this data, it can be calculated that the company managed to post a net profit of just over zł.52 million for 2005. This is the best result in PGF's history, almost 23% better than that recorded in 2004. Investors were pleased to hear the news and pushed PGF's share price up yesterday by 4%. "Equally important was the fulfillment of strategic goals. We have built a company which can effectively supply Polish patients with drugs," said PGF president, Jacek Szwajcowski. (Puls Biznesu, p. 11) A.K.